VictorOrellanaMDMSc

PubMed

• 5 citations
  Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
  Chang, A., Koff, J., Lai, L., Orellana-Noia, V., Surati, M., Leal, A., Ellis, M., Wali, B., Moreno, A., Linderman, S., O'Leary, C., Allen, P., Churnetski, M., Dhodapka...> ;Blood Advances. 2023 Jun 13
• TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma.
  Max J Gordon, David A Bond, Adam S Kittai, Neda Amirmokhtari, Abigail Steinbrunner, Allison Huffman, Victor Orellana-Noia, Geoffrey Shouse, Jonathon B Cohen, Tycel Phi...> ;Haematologica. 2023 Nov 1
• 4 citations
  Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
  Sanjal H Desai, Michael A Spinner, Kevin David, Veronika Bachanova, Gaurav Goyal, Brad Kahl, Kathleen Dorritie, Jacques Azzi, Vaishalee P Kenkre, Sally Arai, Cheryl Ch...> ;American Journal of Hematology. 2023 Mar 1
• 7 citations
  Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
  Brian T Hess, Anshu Giri, Yeonhee Park, Krina K Patel, Brian K Link, Grzegorz S Nowakowski, Seth M Maliske, Sonia Fortin, Julio C Chavez, Hayder Saeed, Brian T Hill, A...> ;American Journal of Hematology. 2023 Feb 1
• 3 citations
  A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.
  Matthew J Cortese, Wei Wei, Sebastian Cerdeña, Marcus P Watkins, Marissa Olson, Gray Jodon, Jeff Kaiser, Bradley Haverkos, Mitchell E Hughes, Esin Namoglu, Natalie S G...> ;Leukemia & Lymphoma. 2023 Jan 1
• 3 citations
  Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
  Chang, A., Akhtar, A., Lai, L., Orellana-Noia, V., Linderman, S., McCook-Veal, A., Switchenko, J., Saini, M., Valanparambil, R., Blum, K., Allen, P., Lechowicz, M., Ro...> ;Cancer Research Communications. 2022 Dec 1
• 5 citations
  Secondary Central Nervous System Lymphoma: Updates in Treatment and Prophylaxis Strategies.
  Victor Orellana-Noia, Aseala Abousaud> ;Current Treatment Options in Oncology. 2022 Oct 1
• 27 citations
  Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
  Chang, A., Akhtar, A., Linderman, S., Lai, L., Orellana-Noia, V., Valanparambil, R., Ahmed, H., Zarnitsyna, V., McCook-Veal, A., Switchenko, J., Koff, J., Blum, K., Ay...> ;Journal of Clinical Oncology. 2022 Sep 10
• 9 citations
  Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
  Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J Voorhees, Natalie S Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T...> ;Blood Advances. 2021 Sep 28
• 42 citations
  Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
  Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow, Mary-Kate Malecek, Marcus P Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana H. ...> ;Blood. 2021 Sep 27
• 17 citations
  HIV-associated Burkitt lymphoma: Outcomes from a US-UK collaborative analysis
  Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim...> ;Blood Advances. 2021 Jul 27
• 12 citations
  Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
  Adam Zayac, Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie, Catherine Wei, Seo-Hyun Kim, Seema Naik, Suchitra Sundaram, Nishitha...> ;Haematologica. 2021 Jul 1
• 44 citations
  Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
  Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Daniel Rector, Suchitra Sundaram, Nishitha Reddy, Yong Lin, ...> ;Blood. 2021 Jan 21
• 16 citations
  Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure
  Emily C. Ayers, Shaoying Li, L. Jeffrey Medeiros, David A. Bond, Kami J. Maddocks, Pallawi Torka, Angel Mier Hicks, Madeira Curry, Nina D. Wagner-Johnston, Reem Karmal...> ;Cancer. 2020 Jan 15
• 6 citations
  Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia
  Victor M Orellana-Noia, Michael G. Douvas> ;Current Hematologic Malignancy Reports. 2018 Apr 1
• The Masquerading Cyst: Extraparenchymal Neurocysticercosis Presenting as Acute Meningitis.
  Kelsey Ripp, Victor Orellana, Caitlin M Dugdale, Michael Punsoni, Curtis E. Doberstein, Curt G. Beckwith> ;The American Journal of Medicine. 2016 Mar 1
• 59 citations
  Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis.
  Joseph J. Maleszewski, Victor Orellana, David O. Hodge, Uwe Kühl, Heinz-Peter Schultheiss, Leslie T. Cooper> ;The American Journal of Cardiology. 2015 Jun 15
• Join now to see all

Abstracts/Posters

• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Victor M. Orellana-Noia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
  Victor M. Orellana-Noia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019